2009
January
| January 6 | |
| Implementing Cell and Gene Therapies for Cancer in an Academic Setting |
Malcolm K. Brenner, M.D., Ph.D. Professor, Departments of Pediatrics and of Medicine Director, Center for Cell and Gene Therapy Baylor College of Medicine Houston, TX |
| January 13 | |
| No Lecture. | |
| January 20 | |
| No Lecture. Inauguration Day | |
| January 27 | |
| Development of Targeted Therapies for Neurofibromatosis Type 1 related Plexiform Neurofibromas | Brigitte Widemann, M.D. Investigator Pharmacology and Experimental Therapeutics Section Pediatric Oncology Branch Center for Cancer Research, NCI |
February
| February 3 | |
| No Lecture. NCAB meeting February 2-4 | |
| February 10 | |
| Hematologic Malignancies and their Precursors: An Area of Progression | Ola Landgren, M.D., Ph.D. Investigator Medical Oncology Branch Center for Cancer Research, NCI |
| February 17 | |
| How Shelterin Protects Telomeres | Titia de Lange, Ph.D. Leon Hess Professor Laboratory of Cell Biology and Genetics The Rockefeller University New York, NY |
| February 24 | |
| The Identification and Characterization of Tumor-Initiating Cells in Human Squamous Cell Carcinoma of the Skin | Jonathan Vogel, M.D. Senior Investigator Dermatology Branch Center for Cancer Research, NCI |
General information about Grand Rounds
Lipsett Amphitheater, Building 10, 8:00 - 9:00 a.m.
Telephone Contact: 301-984-7191
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine and The National Institutes of Health. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 17 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Educational Objectives
After attending this activity, the participant should be able to describe the novel aspects of the basic and/or clinical research in cancer prevention, diagnosis or treatment presented by the speaker. Participants should also be able to discuss the potential applications of the research and/or therapeutic approaches presented by the speaker and the impact that this is likely to have in advancing the field of oncology research and practice.
If you are an individual with a disability who needs any assistance or assistive devices to participate in this event, please call Karen Davison at 301-984-7191 by the Thursday prior to the seminar so that we can discuss your needs.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
National Institutes of Health
Back to Top
